SecBot SecBot
SECBOTREPLAY Home › Report › WW

WW · WW International announced an expanded collaboration with Novo Nordisk…

WW International Inc. · PRESS-RELEASE filed Mar 31, 2026 at 07:49 ET

At the news

NEUTRALIMPACT 4/10

PRESS-RELEASE filed Mar 31, 2026 at 07:49 ET

WW International announced an expanded collaboration with Novo Nordisk to offer eligible Med+ members discounted subscription pricing for Wegovy, saving up to $1,200 annually. This enhances access to GLP-1 treatment and reinforces WW's integrated weight health model, though no financial impact on revenue or profitability was quantified.

  • WW International and Novo Nordisk expanded their collaboration to offer subscription pricing for Wegovy to eligible Med+ members.
  • Members can save up to $1,200 per year, or up to $100/month on pens and $50/month on pills, via pre-paid 3, 6, or 12-month plans.
  • The offer applies to all Wegovy pen doses and 9 mg/25 mg pill doses; existing limited-time offers also remain available.
  • WW is a NovoCare® Recognized Care Provider and emphasizes combining medication with lifestyle support for better outcomes.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access